On September 24, 2026, Heidi Overton appeared before a congressional hearing to address her nomination by President Donald Trump to lead the Food and Drug Administration. During the session, Overton was questioned extensively about two significant issues: vaccines and a widely used abortion pill.
Overton made clear her stance on the combined measles, mumps, and rubella (MMR) vaccine, asserting that it is “not lethal” and is “safe and effective.” Her comments came amid ongoing debates surrounding vaccine safety and government mandates. The MMR vaccine, which protects against three serious illnesses, has been validated by numerous studies confirming its safety and efficacy.
In addition to vaccines, Overton faced inquiries regarding a frequently used abortion pill, reflecting its contentious position in regulatory discussions. Although details about her specific statements on the pill were not provided, the questioning underscored the importance of these issues within the agency’s purview.
The hearing highlighted the critical role that the FDA plays in public health and policy, especially concerning vaccine safety and approval processes for medications. Overton’s responses aimed to reassure both policymakers and the public of her commitment to science-based regulations.
Understanding Inflammation: Myths and Facts 
Calm Parenting: Strategies to Manage Stress 
Trump’s Executive Order to Combat Mosquitoes and Ticks in D.C. 
Overcoming Weight Loss Challenges: Brain Health and GLP-1 Medications 
Supporting Children’s Mental Health at Home: Practical Steps for Parents 
Abdul El-Sayed’s Strategy to Attract Health-Conscious Voters in Michigan